Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
People›
John M Nehra
AddedMar 31, 2024
UpdatedMay 1, 2026
John M Nehra

John M Nehra

Board Member, Cvrx

John M Nehra's Career

Cvrx
Cvrx

Minneapolis, MN, US

Board Member· Board
DaVita
DaVita

Denver, CO, US

Board Member· Board

Create your profile now and gain access to exclusive deals and high-potential startups.

aVenture product preview
aVenture product preview
aVenture product preview

John M Nehra's Career

Cvrx
Cvrx
Public$390.6M1602001Minneapolis, MN, US
Board Member· Board

Leadership at Cvrx

Mudit K JainMudit K JainBoard Member
Jim ShapiroJim ShapiroBoard Member
Josep Ll. SanfeliuJosep Ll. SanfeliuBoard Member
Nadim YaredNadim YaredBoard Member
Joseph P. SlatteryJoseph P. SlatteryBoard Member
Geoff PardoGeoff PardoBoard Member

Similar to Cvrx

BarologicsBarologicsCarver, MN, USMedical Devicesest. 2017BarologicsCarver, MN, US · est. 2017

Innovative medical tech company in Carver, MN treating hypertension with disruptive technology.

Series A · $11.5M6
CardieXCardieXItasca, IL, USHealthcare, Medical Devicesest. 2005CardieXItasca, IL, US · est. 2005

CardieX: A global health tech firm specializing in hypertension and cardiovascular disease solutions.

Public · $75k36
MvrxMvrxBelmont, CA, USMedical Devicesest. 2009MvrxBelmont, CA, US · est. 2009

MVRx: A medical device company offering ARTO System, an innovative therapy for heart failure and mitral valve regurgitation.

Series A · $5.9M30
DaVita
DaVita
Public$750M70k1994Denver, CO, US
Board Member· Board

Leadership at DaVita

Paul DiazPaul DiazBoard Member
Pamela ArwayPamela ArwayBoard Member
Chuck BergChuck BergBoard Member
Javier RodriguezJavier RodriguezCEO

Similar to DaVita

Liberty DialysisLiberty DialysisMercer Island, WA, USDialysisest. 2002Liberty DialysisMercer Island, WA, US · est. 2002

Liberty Dialysis operates clinics, providing dialysis services and kidney disease outreach programs.

Private Equity · $350M7.5k
Pure Life RenalPure Life RenalHollywood, FL, USDialysis, Healthcareest. 2013Pure Life RenalHollywood, FL, US · est. 2013

Pure Life Renal: A leading kidney dialysis service provider, partnering with nephrologists for clinic growth.

Series B · $21M52
Fresenius Medical Care North AmericaFresenius Medical Care North AmericaWaltham, MA, USDialysis Care, Productsest. 1996Fresenius Medical Care North AmericaWaltham, MA, US · est. 1996

Waltham-based FMS ENA Home offers quality dialysis for improved health and life.

Public · $99.7M30

John M Nehra's Similar Executives & Operators

Jay Geoffrey WacherJay Geoffrey WacherBoard Member · BukalapakSoemantri BrodjonegoroSoemantri BrodjonegoroBoard Member · BukalapakLau Eng BoonLau Eng BoonBoard Member · BukalapakWILL WEI CHENGWILL WEI CHENGBoard Member · DiDiMason YeoMason YeoBoard Member · KakaoJaeHong ChoiJaeHong ChoiBoard Member · KakaoYun SeokYun SeokBoard Member · KakaoBrian KimBrian KimBoard Member · Kakao

People Similar to John M Nehra

John AbrahamJohn AbrahamBoard Member · CrystallizeJohn C McNeirneyJohn C McNeirneyBoard Member · DermatrendsJohn E AhernJohn E AhernBoard Member · NMT MedicalDr John ZakDr John ZakBoard Member · TheraVascJohn G DanhaklJohn G DanhaklBoard Member · PssiDr John J AlamDr John J AlamBoard Member · Pathfinder Cell Therapy